Castle Biosciences (CSTL) Profit After Tax (2018 - 2025)
Historic Profit After Tax for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to -$501000.0.
- Castle Biosciences' Profit After Tax fell 12208.02% to -$501000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.2 million, marking a year-over-year decrease of 30141.56%. This contributed to the annual value of $18.2 million for FY2024, which is 13174.92% up from last year.
- Latest data reveals that Castle Biosciences reported Profit After Tax of -$501000.0 as of Q3 2025, which was down 12208.02% from $4.5 million recorded in Q2 2025.
- In the past 5 years, Castle Biosciences' Profit After Tax registered a high of $9.6 million during Q4 2024, and its lowest value of -$29.2 million during Q1 2023.
- For the 5-year period, Castle Biosciences' Profit After Tax averaged around -$8.4 million, with its median value being -$6.4 million (2021).
- As far as peak fluctuations go, Castle Biosciences' Profit After Tax plummeted by 103938.11% in 2023, and later soared by 47170.54% in 2024.
- Castle Biosciences' Profit After Tax (Quarter) stood at -$6.4 million in 2021, then plummeted by 220.65% to -$20.6 million in 2022, then soared by 87.49% to -$2.6 million in 2023, then surged by 471.71% to $9.6 million in 2024, then tumbled by 105.22% to -$501000.0 in 2025.
- Its Profit After Tax stands at -$501000.0 for Q3 2025, versus $4.5 million for Q2 2025 and -$25.8 million for Q1 2025.